Exact Mass: 427.312

Exact Mass Matches: 427.312

Found 169 metabolites which its exact mass value is equals to given mass value 427.312, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Linoleoyl Phenylalanine

2-(octadeca-9,12-dienamido)-3-phenylpropanoic acid

C27H41NO3 (427.3086)


N-linoleoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Phenylalanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Valine

2-(docosa-4,7,10,13,16,19-hexaenamido)-3-methylbutanoic acid

C27H41NO3 (427.3086)


N-docosahexaenoyl valine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Valine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Valine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Valine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Peimisine

5-hydroxy-2,3,6,15-tetramethyl-3a,4,5,6,7,7a-hexahydro-3H-spiro[furo[3,2-b]pyridine-2,14-tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadecan]-15-en-8-one

C27H41NO3 (427.3086)


   

Pimavanserin

Urea, N-((4-fluorophenyl)methyl)-N-(1-methyl-4-piperidinyl)-n-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)

C25H34FN3O2 (427.2635)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.

   

4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol

5-hydroxy-2,15-dimethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-ene-6-carboxylate

C28H43O3 (427.3212)


4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol can be found in a number of food items such as white lupine, chinese chives, radish, and pear, which makes 4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol a potential biomarker for the consumption of these food products.

   

Peimisine

Spiro[9H-benzo[a]fluorene-9,2(3H)-furo[3,2-b]pyridin]-5(6H)-one, 1,2,3,3a,4,4,4a,5,6,6a,6b,7,7,7a,8,11,11a,11b-octadecahydro-3-hydroxy-3,6,10,11b-tetramethyl-, (2R,3S,3R,3aS,4aS,6S,6aR,6bS,7aR,11aS,11bR)-

C27H41NO3 (427.3086)


Peimisine is an alkaloid. Peimisine is a natural product found in Fritillaria anhuiensis, Fritillaria cirrhosa, and other organisms with data available. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3].

   
   
   
   

Peimisine

(3S,3R,3aS,4aS,6S,6aR,6bS,7aR,9R,11aS,11bR)-3-hydroxy-3,6,10,11b-tetramethyl-spiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[4,5-b]pyridine]-5-one

C27H41NO3 (427.3086)


Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3].

   

Solaspiralidine

Solaspiralidine

C27H41NO3 (427.3086)


   
   

(3R*,4S*,5S*,6S*,8R*,10R*)-3-[1,2,4a,5,6,7,8,8a-octahydro-3,6,8-trimethyl-2-[(E)-1-methyl-1-propenyl]-1-naphthalenyl]carbonyl-5-butoxy-1,5-dihydro-5-methyl-2H-pyrrol-2-one|ascosalipyrrolidinone A

(3R*,4S*,5S*,6S*,8R*,10R*)-3-[1,2,4a,5,6,7,8,8a-octahydro-3,6,8-trimethyl-2-[(E)-1-methyl-1-propenyl]-1-naphthalenyl]carbonyl-5-butoxy-1,5-dihydro-5-methyl-2H-pyrrol-2-one|ascosalipyrrolidinone A

C27H41NO3 (427.3086)


   

(25R)-23,26-epimino-3beta-hydroxy-5alpha-cholest-23(N)-ene-6,22-dione

(25R)-23,26-epimino-3beta-hydroxy-5alpha-cholest-23(N)-ene-6,22-dione

C27H41NO3 (427.3086)


   
   

N-Methyl-solasodine

N-Methyl-solasodine

C28H45NO2 (427.345)


   

(22R,25S)-N-methyl-22,26-epiminocholest-3,6-dione|puqietinedione

(22R,25S)-N-methyl-22,26-epiminocholest-3,6-dione|puqietinedione

C28H45NO2 (427.345)


   
   

Veralodisinol

Veralodisinol

C27H41NO3 (427.3086)


   

myceliothermophin C

myceliothermophin C

C27H41NO3 (427.3086)


   

12beta-hydroxy-(25S)-22betaN-spirosol-4-en-3-one

12beta-hydroxy-(25S)-22betaN-spirosol-4-en-3-one

C27H41NO3 (427.3086)


   
   

(23R)-17,23-epoxy-veratra-5,12-diene-3beta,11beta-diol|deoxojervin-11beta-ol|Servin-11beta-ol|Veratrobasin

(23R)-17,23-epoxy-veratra-5,12-diene-3beta,11beta-diol|deoxojervin-11beta-ol|Servin-11beta-ol|Veratrobasin

C27H41NO3 (427.3086)


   

(20Xi,23Xi,25Xi,26Xi)-23,26-epoxy-3beta-hydroxy-(5alpha)-16,28-seco-solanid-22(28)-en-6-one|Korsevinin|korsevinine

(20Xi,23Xi,25Xi,26Xi)-23,26-epoxy-3beta-hydroxy-(5alpha)-16,28-seco-solanid-22(28)-en-6-one|Korsevinin|korsevinine

C27H41NO3 (427.3086)


   

Brachystamide E|brachystamide-E|N-isobutyl-16-(3,4-methylenedioxyphenyl)-2E,4E-hexadecadienamide

Brachystamide E|brachystamide-E|N-isobutyl-16-(3,4-methylenedioxyphenyl)-2E,4E-hexadecadienamide

C27H41NO3 (427.3086)


   

Geotrichum alkaloid A 25822D

Geotrichum alkaloid A 25822D

C28H45NO2 (427.345)


   

arginylprolylarginine

arginylprolylarginine

C17H33N9O4 (427.2655)


   

Sipeimone

Sipeimone

C27H41NO3 (427.3086)


Origin: Plant; SubCategory_DNP: Steroidal alkaloids, Veratrum alkaloids

   

Ala Ile Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Ile Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Lys Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Lys Leu Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Lys Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Lys Pro Leu

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Leu Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Leu Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Lys Leu

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Leu Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Ile Ala Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ile Ala Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   
   

Ile Lys Ala Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ile Lys Pro Ala

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Ile Pro Ala Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Ile Pro Lys Ala

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   
   

Lys Ala Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Ala Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Ala Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Ala Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Ile Ala Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Ile Pro Ala

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Lys Leu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Leu Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Ala Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Ala Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Ile Ala

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Leu Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Leu Ala Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Leu Ala Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Leu Lys Ala Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Leu Lys Pro Ala

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Leu Pro Ala Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Leu Pro Lys Ala

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   
   

Pro Ala Ile Lys

(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Leu Lys

(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Ile Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Ile Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]propanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Ala Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]propanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Leu Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Leu Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Leu Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   

cyclopropyl amide

N-ethyl-9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-cyclopropyl amide

C26H37NO4 (427.2722)


   

PGF2&alpha

N-[(2-hydroxy-1-hydroxymethyl)ethyl]-9α,11α,15S-trihydroxy-prosta-5Z,13E-dien-1-amide

C23H41NO6 (427.2934)


   

PGF2alpha-dihydroxypropanylamine

N-(1,3-dihydroxypropan-2-yl)-9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl amine

C23H41NO6 (427.2934)


   

dioctyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

dioctyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

C20H46NO6P (427.3063)


   

2-(tert-butylamino)ethyl 2-methylprop-2-enoate,butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

2-(tert-butylamino)ethyl 2-methylprop-2-enoate,butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C23H41NO6 (427.2934)


   
   

sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate

sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate

C21H42NNaO4S (427.2732)


   

4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol

5-hydroxy-2,15-dimethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-ene-6-carboxylate

C28H43O3 (427.3212)


4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol can be found in a number of food items such as white lupine, chinese chives, radish, and pear, which makes 4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol a potential biomarker for the consumption of these food products. 4α-carboxy-5α-cholesta-8,24-dien-3β-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4α-carboxy-5α-cholesta-8,24-dien-3β-ol can be found in a number of food items such as white lupine, chinese chives, radish, and pear, which makes 4α-carboxy-5α-cholesta-8,24-dien-3β-ol a potential biomarker for the consumption of these food products.

   

4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol

3-hydroxy-10,13-dimethyl-17-(6-methylhept-5-en-2-yl)-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylate

C28H43O3- (427.3212)


4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol can be found in a number of food items such as white lupine, chinese chives, radish, and pear, which makes 4alpha-carboxy-5alpha-cholesta-8,24-dien-3beta-ol a potential biomarker for the consumption of these food products.

   

4alpha-Carboxyzymosterol(1-)

4alpha-Carboxyzymosterol(1-)

C28H43O3- (427.3212)


   

3,24-Dioxo-cholest-4-en-26-oate

3,24-Dioxo-cholest-4-en-26-oate

C27H39O4- (427.2848)


   

4alpha-carboxy-5alpha-cholesta-7,24-dien-3beta-ol

4alpha-carboxy-5alpha-cholesta-7,24-dien-3beta-ol

C28H43O3- (427.3212)


   

[4-[[(2S)-1-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentyl]-(diaminomethylidene)azanium

[4-[[(2S)-1-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentyl]-(diaminomethylidene)azanium

C20H39N6O4+ (427.3033)


   

N-Linoleoyl Phenylalanine

N-Linoleoyl Phenylalanine

C27H41NO3 (427.3086)


   

2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-methylbutanoic acid

2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-methylbutanoic acid

C27H41NO3 (427.3086)


   
   

4-[(2S)-2-[2-(4-ethoxyphenyl)ethylamino]-3-[[(2S)-1-(methylamino)hexan-2-yl]amino]propyl]phenol

4-[(2S)-2-[2-(4-ethoxyphenyl)ethylamino]-3-[[(2S)-1-(methylamino)hexan-2-yl]amino]propyl]phenol

C26H41N3O2 (427.3199)


   

2-[4-[1-(2-Fluorophenyl)-4-piperidinyl]-1-[(3-methoxyphenyl)methyl]-2-piperazinyl]ethanol

2-[4-[1-(2-Fluorophenyl)-4-piperidinyl]-1-[(3-methoxyphenyl)methyl]-2-piperazinyl]ethanol

C25H34FN3O2 (427.2635)


   

(2S)-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

C17H33N9O4 (427.2655)


   
   
   

4-Carboxyzymosterol(1-)

4-Carboxyzymosterol(1-)

C28H43O3- (427.3212)


A steroid acid anion that is the conjugate base of 4-carboxyzymosterol, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(2E)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadec-2-enoate

(2E)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadec-2-enoate

C24H43O6- (427.3059)


   

(E,17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctadec-2-enoate

(E,17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctadec-2-enoate

C24H43O6- (427.3059)


   

NAGly 10:0/12:0

NAGly 10:0/12:0

C24H45NO5 (427.3298)


   

NAGly 12:0/10:0

NAGly 12:0/10:0

C24H45NO5 (427.3298)


   

NAGly 11:0/11:0

NAGly 11:0/11:0

C24H45NO5 (427.3298)


   

Cer 8:0;3O/16:2;(2OH)

Cer 8:0;3O/16:2;(2OH)

C24H45NO5 (427.3298)


   

Cer 12:1;3O/12:1;(2OH)

Cer 12:1;3O/12:1;(2OH)

C24H45NO5 (427.3298)


   

(8Z,11Z,14Z,17Z,20Z,23Z)-N-(2-hydroxyethyl)hexacosa-8,11,14,17,20,23-hexaenamide

(8Z,11Z,14Z,17Z,20Z,23Z)-N-(2-hydroxyethyl)hexacosa-8,11,14,17,20,23-hexaenamide

C28H45NO2 (427.345)


   

Pimavanserin

Pimavanserin

C25H34FN3O2 (427.2635)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.

   

leupeptin(1+)

leupeptin(1+)

C20H39N6O4 (427.3033)


A guanidinium ion that is the conjugate acid of leupeptin, arising from protonation of the guanidino group; major species at pH 7.3.

   

oscr#31(1-)

oscr#31(1-)

C24H43O6 (427.3059)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#31, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#31(1-)

ascr#31(1-)

C24H43O6 (427.3059)


Conjugate base of ascr#31

   
   
   
   
   

NA-Met 19:1(9Z)

NA-Met 19:1(9Z)

C24H45NO3S (427.312)


   

NA-PABA 20:2(11Z,14Z)

NA-PABA 20:2(11Z,14Z)

C27H41NO3 (427.3086)


   

NA-Phe 18:2(9E,12E)

NA-Phe 18:2(9E,12E)

C27H41NO3 (427.3086)


   

NA-Phe 18:2(9Z,12Z)

NA-Phe 18:2(9Z,12Z)

C27H41NO3 (427.3086)


   

NA-Val 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Val 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C27H41NO3 (427.3086)


   
   
   
   
   

Cer 8:0;O3/16:2;O

Cer 8:0;O3/16:2;O

C24H45NO5 (427.3298)


   

ST 24:4;O2;Gly

ST 24:4;O2;Gly

C26H37NO4 (427.2722)


   

(3s,4as,6ar,6bs,9s,10ar,11as,11br)-9-[(1s)-1-[(2r,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6bs,9s,10ar,11as,11br)-9-[(1s)-1-[(2r,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

(5s)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5s)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,11r,11as,11br)-3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,11r,11as,11br)-3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

C27H41NO3 (427.3086)


   

(2r)-n-[(3r)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

(2r)-n-[(3r)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

C25H37N3O3 (427.2835)


   

(3s,4as,6ar,6bs,9s,11as,11br)-9-[(1s)-1-[(2r,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6bs,9s,11as,11br)-9-[(1s)-1-[(2r,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

3-[2-(but-2-en-2-yl)-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

3-[2-(but-2-en-2-yl)-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

C27H41NO3 (427.3086)


   

2-{2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

2-{2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

C27H41NO3 (427.3086)


   

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

(3s,4as,6as,6br,9s,10ar,11ar,11br)-9-[(1s)-1-[(2s,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6as,6br,9s,10ar,11ar,11br)-9-[(1s)-1-[(2s,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

(1r,2s,6s,9s,10r,11r,14s,15s,18s,23r,24s)-10-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosane-17,20-dione

(1r,2s,6s,9s,10r,11r,14s,15s,18s,23r,24s)-10-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosane-17,20-dione

C27H41NO3 (427.3086)


   

3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

C27H41NO3 (427.3086)


   

(3s,3'r,3'as,4as,6's,6ar,6bs,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

(3s,3'r,3'as,4as,6's,6ar,6bs,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO3 (427.3086)


   

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]propan-1-one

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]propan-1-one

C27H41NO3 (427.3086)


   

16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

C27H41NO3 (427.3086)


   

(5r)-3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

(5r)-3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

C27H41NO3 (427.3086)


   

9-[1-(1,5-dimethylpiperidin-2-yl)ethyl]-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

9-[1-(1,5-dimethylpiperidin-2-yl)ethyl]-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

C27H41NO3 (427.3086)


   

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

(5s)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5s)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

2-(1-{7-hydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-1-yl}ethyl)-5-methyl-5,6-dihydro-4h-pyridin-3-one

2-(1-{7-hydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-1-yl}ethyl)-5-methyl-5,6-dihydro-4h-pyridin-3-one

C27H41NO3 (427.3086)


   

9-[1-(1,5-dimethylpiperidin-2-yl)ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

9-[1-(1,5-dimethylpiperidin-2-yl)ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

C27H41NO3 (427.3086)


   

3-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

3-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(4br,10as)-3-(2-carboxyethyl)-2-(carboxylatomethyl)-4b,7,7,10a-tetramethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

(4br,10as)-3-(2-carboxyethyl)-2-(carboxylatomethyl)-4b,7,7,10a-tetramethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

C26H37NO4 (427.2722)


   

3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO3 (427.3086)


   

(5r)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5r)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(3'ar,4ar,6as,6br,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

(3'ar,4ar,6as,6br,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO3 (427.3086)


   

(3s,4as,6ar,6bs,9s,11as,11br)-9-[(1r)-1-[(2s,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6bs,9s,11as,11br)-9-[(1r)-1-[(2s,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

(3s,4as,6ar,6br,9s,10ar,11as,11br)-9-[(1s)-1-[(2r,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6br,9s,10ar,11as,11br)-9-[(1s)-1-[(2r,5s)-1,5-dimethylpiperidin-2-yl]ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

(2e,4e)-16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

(2e,4e)-16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

C27H41NO3 (427.3086)


   

7-hydroxy-9a,11a-dimethyl-1-[1-(5-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

7-hydroxy-9a,11a-dimethyl-1-[1-(5-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

(2s)-n-[(3s)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

(2s)-n-[(3s)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

C25H37N3O3 (427.2835)


   

(3s,4as,6ar,6bs,9s,10ar,11as,11br)-9-[(1s)-1-(1,5-dimethylpiperidin-2-yl)ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6bs,9s,10ar,11as,11br)-9-[(1s)-1-(1,5-dimethylpiperidin-2-yl)ethyl]-3-hydroxy-10a,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,9h,10h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO2 (427.345)


   

(1r,3as,3bs,5as,7s,9ar,9br,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

(1r,3as,3bs,5as,7s,9ar,9br,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-6-one

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-6-one

C27H41NO3 (427.3086)


   

n-(2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl)-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

n-(2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl)-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

C25H37N3O3 (427.2835)


   

(5r)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5r)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,10r,11ar,11br)-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,10-diol

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,10r,11ar,11br)-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,10-diol

C27H41NO3 (427.3086)